Studies on Alzheimer’s disease have shown that mice with BBB-specific GLUT1 deficiency exhibit reduced cerebral microvascular degeneration, decreased cerebral blood flow, and accelerated APP deposition (Winkler et al., 2015). This evidence concerns the gene SLC2A1 and early-onset autosomal dominant Alzheimer disease.